Oxaliplatin: a review of evolving concepts. - Wikidata - awgldk - TriplyDB

Oxaliplatin: a review of evolving concepts.

Oxaliplatin: a review of evolving concepts.

http://www.wikidata.org/entity/Q34569008

about

Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.Oxaliplatin and its enantiomer induce different condensation dynamics of single DNA molecules Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.The role of oxaliplatin in the management of upper gastrointestinal tract malignancies.Platinum-containing regimens for metastatic breast cancer.Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.

P2860

Q24655188-3DEFED0A-08AD-490B-9287-455755830C35 Q28074614-3C526E0B-6414-4E18-8C15-318A1EC0D599 Q33383287-317634B0-32E0-4F2E-A117-E28185EC75C5 Q34949875-BD400D52-3E0B-47C7-88FC-7B7A1A82A88F Q37182939-63C97059-E0FA-4846-B5A3-871C8B89E1CA Q38097811-D92051A6-06B8-4DA0-A74C-3F369E393816 Q38712631-9AE6D16B-8A6A-4F4F-B3CD-765CA1F7C0D1 Q43183942-0BFECA72-447D-4838-97D5-77CE12C83758 Q44938504-00E1D7F4-F468-4571-9C02-99CFECA8D292

P2860

Oxaliplatin: a review of evolving concepts.

http://www.wikidata.org/entity/Q34569008

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Oxaliplatin: a review of evolving concepts.

@ast

Oxaliplatin: a review of evolving concepts.

@en

Oxaliplatin: a review of evolving concepts.

@nl

type

label

Oxaliplatin: a review of evolving concepts.

@ast

Oxaliplatin: a review of evolving concepts.

@en

Oxaliplatin: a review of evolving concepts.

@nl

prefLabel

Oxaliplatin: a review of evolving concepts.

@ast

Oxaliplatin: a review of evolving concepts.

@en

Oxaliplatin: a review of evolving concepts.

@nl

P1433

Q34569008-42AC61DA-167B-470A-BDCE-2D46473AC274

P1476

Q34569008-19385484-8B90-4A39-B6FB-C6764CAA5595

P2093

Q34569008-08E0D59F-5534-40A9-AB76-F73B0774B98C

Q34569008-18C563D0-5B8D-40AD-914D-5228B5F2C577

Q34569008-77ED33C9-AE45-4FBB-A2F8-27165420094A

Q34569008-9165578F-FD6A-4C6C-98A1-6EC3C7D548BE

Q34569008-BC1BD455-B564-4434-9CEC-13FEE04632E7

P2860

Q34569008-02E2BEB7-C84E-41A1-90BB-41FCCAA322C6

Q34569008-030B0BBB-3D40-4303-AEB7-7653A0B62B2A

Q34569008-05F75759-3252-4396-A57B-3428A48501B3

Q34569008-07D8D34C-E659-469D-946E-01A8A3800090

Q34569008-08BD4055-4A5E-4C99-96AA-D7FB101169D1

Q34569008-0EAD79B6-AE85-4556-AECF-9EBED50E8D5C

Q34569008-106709C9-C82D-4A5E-BFD2-662DDCAD7A09

Q34569008-14574454-284E-4B6F-B6FA-A2DAAE5519CE

Q34569008-1644B56C-0DE2-4309-B0D4-897B0AC5DC8E

Q34569008-1707C18C-7BF7-45C4-98BE-8100E7417D78

P304

Q34569008-4A40EB2D-69F7-4987-A3BD-6B81457A80C7

P31

Q34569008-521EA3A8-CEE7-4775-9703-5C1B874C9BA1

P356

Q34569008-085300CF-50F8-4D22-A857-B1F0C405B93B

P433

Q34569008-8BFAE048-B27F-43A1-967E-FF106691EA12

P478

Q34569008-EC9B397D-1D43-45F8-93E6-27EBC841F57F

P577

Q34569008-5190252D-F444-470D-926F-CCFBFFE65CF0

P698

Q34569008-7B2E7AE2-19DD-4E59-B365-55407FE10F6C

P356

P1433

Cancer Investigation

P1476

Oxaliplatin: a review of evolving concepts.

@en

P2093

David B Bregman

http://www.w3.org/2001/XMLSchema#string

Martin A Graham

http://www.w3.org/2001/XMLSchema#string

Percy Ivy

http://www.w3.org/2001/XMLSchema#string

Sridhar Mani

http://www.w3.org/2001/XMLSchema#string

Stephen G Chaney

http://www.w3.org/2001/XMLSchema#string

P2860

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

Molecular mechanism of nucleotide excision repair.

A novel function of emodin: enhancement of the nucleotide excision repair of UV- and cisplatin-induced DNA damage in human cells.

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.

Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.

Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.

P304

246-263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/CNV-120001152

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11901545

http://www.w3.org/2001/XMLSchema#string